Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
Akio Mori, Yuzuru Imai, Nobutaka Hattori
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3301-3301
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis
Ting Shen, Yumei Yue, Tingting He, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 170
Brain lipidomics: From functional landscape to clinical significance
Jong Hyuk Yoon, Youngsuk Seo, Yeon Suk Jo, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 140
Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology
Magdalena I. Ivanova, Yuxi Lin, Young‐Ho Lee, et al.
Biophysical Chemistry (2020) Vol. 269, pp. 106507-106507
Open Access | Times Cited: 129
The 3D structure of lipidic fibrils of α-synuclein
Benedikt Frieg, Leif Antonschmidt, Christian Dienemann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
Nicolò Bisi, Lucia Feni, Kaliroi Peqini, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 48
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders
Daniel Erskine, David J. Koss, Viktor I. Korolchuk, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 511-526
Open Access | Times Cited: 45
The structural heterogeneity of α-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds
Jiaxing Chen, Sofia Zaer, Paz Drori, et al.
Structure (2021) Vol. 29, Iss. 9, pp. 1048-1064.e6
Open Access | Times Cited: 45
Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
Subhashree Sahoo, Amrita Arpita Padhy, Varsha Kumari, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5379-5407
Closed Access | Times Cited: 37
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
Kensuke Daida, Shotaro Shimonaka, Kahori Shiba‐Fukushima, et al.
Movement Disorders (2022) Vol. 37, Iss. 10, pp. 2075-2085
Open Access | Times Cited: 25
Small molecule modulators of Alpha-Synuclein Aggregation and Toxicity: Pioneering an Emerging Arsenal Against Parkinson’s Disease
Ishfaq Ahmad Ahanger, Tanveer Ali Dar
Ageing Research Reviews (2024) Vol. 101, pp. 102538-102538
Closed Access | Times Cited: 5
Nazo, the Drosophila homolog of the NBIA-mutated protein–c19orf12, is required for triglyceride homeostasis
Perinthottathil Sreejith, Sara Lolo, Kristen R. Patten, et al.
PLoS Genetics (2024) Vol. 20, Iss. 2, pp. e1011137-e1011137
Open Access | Times Cited: 4
Anionic lipid catalyzes the generation of cytotoxic insulin oligomers
Jhinuk Saha, Audrey Wolszczak, Navneet Kaur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Is efficiency of protein incorporations governed by membrane properties? An α-synuclein and ceramide-1-phosphate investigation.
Dominik Drabik, Piotr Hinc, Karolina Cierluk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation
Chunyan Mu, Kaiquan Shao, Mingyu Su, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Elucidating Pathological Mechanisms and Developing Biomarkers of Parkinson's Disease
Taku Hatano
Neurology and Clinical Neuroscience (2025)
Closed Access
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease
Nouara Yahi, Coralie Di Scala, Henri Chahinian, et al.
Glycoconjugate Journal (2021) Vol. 39, Iss. 1, pp. 1-11
Closed Access | Times Cited: 24
Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
Jiewen Qiu, Lijian Wei, Yilin Su, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1166-1166
Open Access | Times Cited: 10
Influence of Cholesterol on the Membrane Binding and Conformation of α-Synuclein
Ziqiang Qi, Menglin Wan, Jun Zhang, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 9, pp. 1956-1964
Closed Access | Times Cited: 8
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
Natalia Siwecka, Kamil Saramowicz, Grzegorz Galita, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2051-2051
Open Access | Times Cited: 8
Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy
Saranna Fanning, Haley Cirka, Jennifer L. Thies, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Parkinson’s disease-associated mutations in α-synuclein alters its lipid-bound state
Sofiya Maltseva, Daniel H. Kerr, Miah J. Turke, et al.
Biophysical Journal (2024) Vol. 123, Iss. 12, pp. 1610-1619
Closed Access | Times Cited: 2
Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year study
Jasmin Galper, Giorgia Mori, Gordon McDonald, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
The Role of Glial Mitochondria in α-Synuclein Toxicity
Yu‐Mi Jeon, Younghwi Kwon, Myungjin Jo, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 17
Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
Kenya Nishioka, Yuzuru Imai, Hiroyo Yoshino, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 713-713
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top